Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheet

v3.7.0.1
Condensed Balance Sheet - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Current Assets:    
Cash and cash equivalents $ 8,790,519 $ 11,578,473
Marketable securities 17,986,160 8,737,107
Prepaid expenses and other current assets 1,199,641 608,517
Total Current Assets 27,976,320 20,924,097
Security Deposits 30,785 30,785
Equipment, Net 86,610 88,650
Total Assets 28,093,715 21,043,532
Current Liabilities:    
Accounts payable and accrued expenses 1,917,739 1,882,500
Deferred Research and Development Arrangement 412,500 450,000
Other Liabilities 65,812 79,204
Warrant Liabilities 9,796,591 1,573,366
Total Liabilities 12,192,642 3,985,070
Commitments and Contingencies (note 14)
Stockholders' Equity:    
Preferred stock, par value $0.0001, 10,000,000 authorized shares, none issued and outstanding
Common stock, par value $0.0001, 50,000,000 authorized shares, 28,452,305 and 23,736,878 issued and outstanding 2,845 2,374
Additional paid-in capital 151,612,110 132,086,419
Accumulated other comprehensive loss (25,705) (6,122)
Accumulated deficit (135,688,177) (115,024,209)
Total Stockholders' Equity 15,901,073 17,058,462
Total Liabilities and Stockholders' Equity $ 28,093,715 $ 21,043,532